267 related articles for article (PubMed ID: 6309290)
1. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
Mauriac L; Wafflart J; Trojani M; Durand M
Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
[TBL] [Abstract][Full Text] [Related]
3. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
4. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
Lampertico P; Stagni F
Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
[No Abstract] [Full Text] [Related]
5. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoma of the male breast and hormone receptors].
Bottero G; Novella V; Spinoglio G
Minerva Med; 1988 Apr; 79(4):281-4. PubMed ID: 2835712
[TBL] [Abstract][Full Text] [Related]
7. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
Mattfeldt T; Neurohr W; Müller A; Klinga K
Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
[No Abstract] [Full Text] [Related]
8. [Hormonal receptors and breast cancer. Review of the literature and personal experience].
Gallo A; Baldi F; Giannantoni C; Dell'Agli P; Caselli G
Minerva Chir; 1988 Mar; 43(5):429-32. PubMed ID: 2840607
[No Abstract] [Full Text] [Related]
9. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the receptor composition of breast tumors with their histological structure; effect of preoperative therapy].
Kuz'mina ZV; Murav'eva NI; Ermilova VD; Vishniakova VV; Letiagin VP
Vestn Akad Med Nauk SSSR; 1985; (8):83-7. PubMed ID: 2998115
[No Abstract] [Full Text] [Related]
11. [Stability of steroid receptors from breast tumors at different storage temperatures].
Locher GW; Burger H; Davis BW; Zava DT
Pathologe; 1984 Mar; 5(2):82-5. PubMed ID: 6326078
[No Abstract] [Full Text] [Related]
12. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen receptor status in breast carcinoma. Results of comparative immunohistochemical and biochemical studies].
Köhler G; Bässler R
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1954-60. PubMed ID: 3024947
[TBL] [Abstract][Full Text] [Related]
15. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
Kasch R; Meissner J; Haack D; Neumann S
Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
[TBL] [Abstract][Full Text] [Related]
16. [Morphologic and morphometric parameters of infiltrating duct carcinoma of the breast and receptor state in fluorescence: correlations in 104 cases (1983 case survey)].
Tunesi G; Anselmi L; Bandelloni R; Gambini C; Reale A; Sementa AR; Bronzini E
Pathologica; 1985; 77(1049):251-8. PubMed ID: 3008066
[No Abstract] [Full Text] [Related]
17. [Estrogen receptors and clinical prognostic factors in breast cancer].
Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
[TBL] [Abstract][Full Text] [Related]
18. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histochemical and biochemical methods in the evaluation of estrogen and progesterone receptor level in human breast cancer. A study of 118 cases.
Mohácsy J; Kádár A; Vallent K; Duffek L; Vass K
Acta Chir Hung; 1988; 29(1):95-105. PubMed ID: 2455948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
